Equities
Aggreko files NYSE IPO for mobile power giant
Glasgow-based Aggreko, a global leader in mobile power and temperature control equipment, has filed for an IPO on the NYSE under the ticker AGKO. Goldman Sachs and J.P. Morgan lead the underwriting syndicate.
Amrize appoints Samuel Poletti as new CFO amid leadership transition
The U.S.-Canada operator names Poletti, a former Holcim finance executive, as CFO following Baris Oran’s departure. A new VP of Investor Relations is also appointed.
Airbus outshines Boeing on valuation, cash flow and debt metrics
Airbus reports a 7.1% net margin and $5.36B free cash flow, while Boeing posts a $11.88B loss in 2024 and struggles with $48.36B in debt. Comparisons show stark contrasts in profitability and leverage.
Tesla halts solar roof sales after decade, shifts focus to panels
Company redirects customers to traditional solar offerings as it scales back innovative roof tile program. Plans for a $10.1 billion Texas solar cell factory remain on track.
AEON Biopharma appoints Paul Lee as interim regulatory director
Former FDA neuroscience deputy director Paul Lee takes interim role to lead regulatory strategy for AEON’s BOTOX biosimilar ABP-450, including FDA interactions under the 351(k) pathway.
Needham lifts SK Hynix stock target to $220 on $40 trillion buyback plan
Analysts upgrade SK Hynix to buy as the chipmaker approves a massive share repurchase program and raises shareholder return targets through 2027.
Nomad Foods shares rise 4.6% after insider purchases, strong Q2 results
Nomad Foods stock gained on insider buying and better-than-expected Q2 earnings, even as broader market benchmarks diverged. Shares remain 23% below their 52-week high.
Braskem files for out-of-court restructuring amid $10 billion debt burden
Petrochemical giant Braskem seeks financial protection in Brazil after its U.S. subsidiary Braskem Idesa filed for Chapter 11 last week. Debt exceeds $10 billion across operations.
European stocks mixed as Iran sanctions, Nvidia loom over week
Euro Stoxx 50 slipped 0.22% as traders awaited U.S. sanctions on Iran, Nvidia earnings and Jackson Hole policy signals. FTSE 100 rose 0.35% on metal gains; SMI flat near 14,447.
Global markets cautious amid geopolitical tensions and Nvidia earnings
Swiss and European equities edge lower as investors await key U.S. data, central bank signals and Nvidia’s AI chip results. Oil and gold move in opposite directions.
Swiss equities slip as SMI lags; Roche, Novartis weigh; Richemont gains
Swiss benchmark SMI falls 0.25% to 14,423 as Roche and Novartis slide, while Richemont leads gains. US futures point to a softer open after a mixed week.
Seplat Energy awards shares to executive directors under 2024 LTIP
Seplat Energy granted 235,572 shares to its CEO under a three-year performance plan, with COO and CFO receiving 164,784 and 156,741 shares respectively. Awards align with deferred bonus policies and performance criteria.
US stocks mixed as Nvidia, Iran tensions weigh; SMI edges lower
Dow ekes out gains while S&P 500 and Nasdaq 100 retreat; Nvidia faces scrutiny ahead of earnings. SMI slips 0.26% as ABB, Roche weigh.
Guardant Health hit with $245.2 mln patent infringement judgment
Federal court orders Guardant Health to pay over $245 million in damages and royalties for infringing TwinStrand Biosciences' sequencing patents, with ongoing 6% royalty rate until 2033.
Applied Optoelectronics shares slump 12% on $600M stock sale plan
Optical-networking firm’s latest at-the-market offering sparks pre-market selloff, extending August losses to 17% amid ongoing dilution concerns despite strong revenue growth.
Hedge funds cut equity exposure at fastest pace in two months
Goldman Sachs Prime Services desk reduced global stock bets at a 2.3 standard-deviation pace, led by technology liquidations, while energy was the sole net buyer.
Eli Lilly's weight-loss pill Foundayo launches in UK, priced at £100-120
The oral GLP-1 treatment, orforglipron, is the second weight-loss pill in the UK after Novo Nordisk's Wegovy. It is available via private prescription while awaiting NHS and EU assessments.
Michael Burry exits Alibaba for JD.com amid valuation shifts
Burry's full exit from Alibaba follows a $10.2 billion share placement at an 8.4% discount, while JD.com trades at a lower multiple and higher free-cash-flow yield. Analysts project divergent margin trajectories through 2030.
Siegfried shares fall 5.3% after UBS downgrade to Neutral
Swiss drugmaker’s stock drops to CHF 76 after UBS cuts rating and price target, citing slower-than-expected US business ramp-up and back-loaded 2026 growth concerns.
Volkswagen faces pivotal restructuring amid cost cuts and capacity reviews
CEO Oliver Blume seeks to slash costs, reduce models and lift margins to 8-10% by 2030 as worker and political resistance mounts. Key German plants and jobs at risk.
DAX holds above 26,000 as investors await Nvidia and Fed cues
German blue-chip index steadies near 26,134 points after Friday’s rebound, but faces resistance toward record highs amid key macro and earnings events this week. Semiconductor and auto shares lag while materials gain.
Nucor shares rise 2.6% on US-Canada steel tariff deal
Nucor surged in pre-market trading after a tentative deal between the U.S. and Canada proposed lowering tariffs on Canadian steel and aluminum exports to 25%.
Inwit shares rise 1.7% after Barclays upgrade to above average
Barclays upgraded Inwit to above average, citing excessive pessimism in contract renewal assumptions. Cellnex also upgraded as European tower stocks rebound.
European stocks flat as investors weigh Iran risks, Fed cues
EuroStoxx 50 and SMI dip 0.1% each while FTSE 100 rises 0.2% as geopolitical tensions and key economic events loom. Nvidia earnings and Jackson Hole meeting in focus.